Medpace Holdings, Inc.
General ticker "MEDP" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $11.3B (TTM average)
Medpace Holdings, Inc. follows the US Stock Market performance with the rate: 58.9%.
Estimated limits based on current volatility of 2.2%: low 561.29$, high 586.56$
Factors to consider:
- Total employees count: 5900 (0.0%) as of 2024
- Top business risk factors: Loss of customer contracts, Pandemic risks, Third-party risks, Customer concentration, Geopolitical risks
- Current price 25.8% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [302.17$, 433.00$]
- 2025-12-31 to 2026-12-31 estimated range: [309.93$, 446.38$]
Financial Metrics affecting the MEDP estimates:
- Negative: with PPE of 26.7 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 21.19 > 18.64
- Positive: 0.33 < Operating cash flow per share per price, % of 5.83
- Positive: Return on assets ratio (scaled to [-100,100]) of 16.14 > 6.04
- Positive: 18.93 < Shareholder equity ratio, % of 39.30 <= 41.86
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -2.31 <= -0.75
Short-term MEDP quotes
Long-term MEDP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,460.00MM | $1,885.84MM | $2,109.05MM |
| Operating Expenses | $1,181.30MM | $1,549.02MM | $1,662.18MM |
| Operating Income | $278.70MM | $336.82MM | $446.87MM |
| Non-Operating Income | $4.16MM | $-1.14MM | $29.05MM |
| Income(Loss) | $282.86MM | $335.68MM | $475.92MM |
| Taxes | $37.49MM | $52.87MM | $71.54MM |
| Profit(Loss)* | $245.37MM | $282.81MM | $404.39MM |
| Stockholders Equity | $386.39MM | $558.95MM | $825.54MM |
| Assets | $1,352.49MM | $1,656.83MM | $2,100.87MM |
| Operating Cash Flow | $388.05MM | $433.37MM | $608.82MM |
| Capital expenditure | $36.88MM | $36.65MM | $36.55MM |
| Investing Cash Flow | $-38.74MM | $-34.63MM | $-28.31MM |
| Financing Cash Flow | $-775.77MM | $-182.64MM | $-154.01MM |
| Earnings Per Share** | $7.58 | $9.21 | $13.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.